세계의 리퍼브 의료장비 시장 : 제품별, 용도별, 최종사용자별, 지역별 - 예측(-2029년)

Refurbished Medical Equipment Market by Product (Imaging (MRI, CT), Patient Monitor, Defibrillator, Dialysis, Lithotripsy, Ventilator, Incubators, Operating & Surgical Equipment), Application (CVS, Cancer, Ob/Gyn), Enduser - Global Forecast to 2029

US $ 4,950 ￦ 7,024,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,437,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,565,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

리퍼브 의료장비 시장 규모는 2024년 169억 3,000만 달러에서 2029년 244억 1,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 7.6%의 CAGR을 기록할 것으로 예상됩니다.

감염성 질환 환자의 증가, 의료기기의 정기적인 발전이 시장을 주도하고 있습니다. 연구개발에 대한 지출 증가와 질병을 감지하기 위한 바이오마커 프로파일링의 사용 확대도 시장 촉진요인으로 작용하고 있습니다. 또한, 인공지능을 탑재한 리퍼브 의료장비가 시장 성장에 영향을 미치고 있습니다.

조사 범위
조사 대상 연도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
검토 단위	금액(달러)
부문	제품별,용도별,최종사용자별,지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

신흥 경제 국가들의 민간 의료 및 신흥 의료 인프라에 대한 투자 증가로 인해 재생의료 영상 장비 시장이 형성되고 있습니다. 이 때문에 CT나 엑스레이 장비와 같은 재생 시스템은 신흥 시장 내 신규 병원들에게 저렴한 가격으로 제공되고 있습니다. 경제적 요인, 기술 발전, 규제 프레임워크 등 다양한 요인들이 재생의료 영상 진단기기 시장의 성장을 촉진하고 있습니다. 재생의료 영상을 다루는 조직은 많은 규제를 준수하고 있으며, 이러한 규제는 업계 표준을 충족하거나 초과하는 것을 보장합니다. 예를 들어, 지멘스 헬시니어스(Siemens Healthineers)와 GE헬스케어(GE Healthcare)는 MRI 시스템과 CT 스캐너의 리퍼브 제품을 보증 및 인증과 함께 제공하고 있습니다.

여러 가지 중요한 요인들이 리퍼브 의료장비 산업에서 병원의 성장을 촉진하고 있습니다. 경제적 압박, 기술 발전, 의료 관련 요인 등 여러 가지 요인이 병원 및 수술 센터에서 리퍼브 의료장비의 세계 성장을 촉진하고 있습니다. 이러한 원인으로는 새로운 의료기기의 가격 상승, 비용 효율적인 의료 솔루션에 대한 요구 증가, 재생 방법의 개선 등이 있습니다. 일반적으로 사용되는 초음파 창문의 좋은 예는 농촌 지역이나 예산이 적은 지역입니다. 새 제품보다 저렴하면서도 고성능을 발휘하기 때문에 자원이 부족한 환경에서도 진단 서비스를 안정적으로 지속할 수 있습니다.

세계의 리퍼브 의료장비 시장에 대해 조사했으며, 제품별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 특허 분석
• 2024-2026년의 주요 회의와 이벤트
• 무역 데이터 분석
• 가격 분석
• 미충족 수요와 주요 문제점
• 생태계 분석
• 공급망 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 기술 분석
• 규제 상황
• 투자와 자금 조달 시나리오
• 상환 시나리오 분석
• AI/생성형 AI가 리퍼브 의료장비 시장에 미치는 영향

제6장 리퍼브 의료장비 시장, 제품별

• 소개
• 의료용 영상 기기
• 수술실과 수술 기기
• 환자 모니터
• 심장병학 기기
• 비뇨기과 기기
• 신경학 기기
• 집중 치료 기기
• 정맥내 치료 시스템
• 내시경 기기
• 기타

제7장 리퍼브 의료장비 시장, 용도별

• 소개
• 심장병 진단
• 비뇨기과 진단
• 신경 진단
• 정형외과 진단
• 생리학적 진단
• 응급의료 진단
• 종양학 진단
• 산부인과 진단
• 기타 진단
• 심장병 치료
• 비뇨기과 치료
• 신경학 치료
• 정형외과 치료
• 생리학 치료
• 응급의료 치료
• 종양학 치료
• 산부인과 치료
• 기타 치료

제8장 리퍼브 의료장비 시장, 최종사용자별

• 소개
• 병원
• 진단 영상 센터
• 학술기관 및 정부기관
• 외래 케어 센터
• 기타

제9장 리퍼브 의료장비 시장, 지역별

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제10장 경쟁 구도

• 소개
• 주요 진출 기업 전략/강점
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 진출 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 평가와 재무 지표
• 제품/브랜드 비교
• 경쟁 시나리오

제11장 기업 개요

• 주요 진출 기업
  • GE HEALTHCARE
  • PHILIPS HEALTHCARE
  • SIEMENS HEALTHINEERS AG
  • STRYKER
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • CANON MEDICAL SYSTEMS CORPORATION
  • DRAGERWERK AG & CO. KGAA
  • NIHON KOHDEN CORPORATION
  • OLYMPUS CORPORATION
  • AVANTE HEALTH SOLUTIONS
  • SOMA TECH INTL.
  • EVERX
  • RADIOLOGY ONCOLOGY SYSTEMS
  • MASTER MEDICAL EQUIPMENT
  • FAIR-MEDICAL INC.
  • FUTURE HEALTH CONCEPTS
  • HILDITCH GROUP LTD.
  • BLOCK IMAGING, INC.
• 기타 기업
  • NATIONWIDE IMAGING SERVICES
  • PACIFIC HEALTHCARE IMAGING
  • VENTURE MEDICAL REQUIP
  • DESERT TECH MEDICAL SYSTEMS INC.
  • HI-TECH INTERNATIONAL
  • AMBER DIAGNOSTICS
  • WHITTEMORE ENTERPRISES
  • TRACO MEDICAL INC.
  • US MED-EQUIP
  • US MEDICAL SYSTEMS
  • MEDLINE INDUSTRIES, INC.
  • DIRECTMED IMAGING
  • AGITO MEDICAL

제12장 부록

ksm

영문 목차

영문목차

The Refurbished medical equipment market is projected to reach USD 24.41 Billion by 2029 from USD 16.93 in 2024, growing at a CAGR of 7.6% during the forecast period. The market is growing due to numerous factors.Increasing cases of infectious diseases, and regular advancements in Refurbished medical equipment drives this market. Rising expenditure in research and development and increase in application of biomarker profiling to detect diseases are other factors. Additionally, the market growth is affected by inclusion of Refurbished medical equipment with artificial intelligence.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	Product, Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"Medical imaging equipment to account for largest market share in 2023."

A market is being formed for the refurbished medical imaging equipment owing to the increased sectored investments in private healthcare and emerging health infrastructures in developing economies. This makes refurbished systems like CT and X-ray machines affordable for new hospitals within emerging markets. Multi-dimensional forces such as economic elements, technological advancement, and regulatory frameworks encourage the growth of refurbished medical imaging equipment markets globally. Organizations dealing in refurbished medical imaging adhere to many regulations since these should guarantee that they meet or exceed the industry standards. Siemens Healthineers and GE Healthcare, for instance, provides refurbished MRI systems and CT scanners with warranties and certifications.

"Hospitals to hold largest share in the market."

Various significant factors are propelling the growth of hospitals in the refurbished medical equipment industry. Numerous causes like economic pressures, technological advancements, and healthcare-related factors have encouraged the global growth of refurbished medical equipment in hospitals and surgical centers. Some of these causes include rising prices for new medical devices, the increasing requirement for cost-effective health-care solutions, and improvements in refurbishment methods. A good example of commonly utilized ultrasound windows is in rural areas or areas with low budgets. They provide high performance while being cheaper than new equipment; thus, they ensure diagnostic services continue even at low-resource settings.

"North America to register largest share in 2023."

The largest share was hold by North America in 2023. North America comprise US and Canada.

Reduced costs are one of the most major factors attracting North America towards refurbished medical equipment. Genuinely refurbished equipment serves as a shake quality alternative to new devices, enabling hospitals to make do even with very restricted budgets. Above all, pressure from the government for sustainability and the reduction of electronic waste in North America adds importance to refurbishing medical equipment. It promises to nullify the environmental impact of thrown-up devices and at the same time promote circular economies. In North America, refurbished medical equipment stands under very stringent regulatory requirements (like FDA in the U.S.). The quality and safety assured make healthcare providers much more confident in purchasing refurbished devices. As well, hospitals and clinics grow their medical arms without making huge financial outlays for the refurbished option to fulfill the high demand for urine ultrasound machines in North America.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-45%, and Tier 3- 20%
• By Designation: C-level-- 35%, Director-level-25%, and Others-40%
• By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America - 5%, Middle East & Africa- 5%

Prominent players in the Refurbished medical equipment market include GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Block Imaging International,Inc. (US), Canon Medical Systems Corp. (Japan), Soma Technology, Inc. (US), and Avante Health Solutions (US), Mindray Medical International (China), Dragerwerk AG & Co. KGAA (Germany), Whittemore Enterprises (U.S.), Stryker (US), Directmed Parts & Services (US), Medline Industries (U.S.), Traco Medical (U.S.), Nihon Kohden Corporation (Japan), Master Medical Equipment (U.S.), and Everx Pvt. Ltd. (US).

Research Coverage

The report comprise segmentation that includes end users, products, applications, and geographic regions. It also discusses the key drivers, restraints, opportunities, and challenges affecting the growth of the Refurbished medical equipment market. The research offers stakeholders an assessment of market potential and challenges, with a focus on key players and competitive landscapes. Additionally, micromarkets are assessed according to their overall to the refurbished medical equipment sector, growth patterns, and potential. The analysis estimates increase in market segment revenues, focusing on five regions.

Key Benefits of Buying the Report:

This research aids new and existing players in the Refurbished medical equipment market to assess the sustainability of their investments by offering detailed information. It offers a dataset to assist in making key decisions. The main advantage of this report includes risk evaluation and offering direction for investment decisions. Market segmentation as per the end-users and geographical areas is offered in the study, that provides analysis and insights. It also provides trends, obstacles, opportunities, and drivers, giving stakeholders the information they need to make strategic decisions.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges impacting the Refurbished medical equipment market growth: rise in prevalence of chronic diseases, cost efficiency as compared to new medical equipment; negative perception for refurbished product quality; updated technology with software integration and regulatory support helps refurbished medical equipment to grow in the market.

Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the refurbished medical equipment industry.

Market Development: Details related to profitable markets: this research discussees the Refurbished medical equipment business in numerous regions.

Market Diversification: Detailed understanding of advanced products, unexplored areas, latest developments, and investment in the market.

Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Avante Health Solutions (US), Soma Technology, Inc. (US) and Canon Medical Systems Coproration(Japan).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS COVERED & GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key secondary sources
    • 2.2.1.2 Key objectives of secondary research
    • 2.2.1.3 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Key primary sources
    • 2.2.2.2 Key objectives of primary research
    • 2.2.2.3 Key industry insights
    • 2.2.2.4 Breakdown of primaries
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Company revenue estimation approach
    • 2.3.1.2 Customer-based market estimation
  • 2.3.2 TOP-DOWN APPROACH
    • 2.3.2.1 Primary interviews
• 2.4 MARKET GROWTH FORECAST
• 2.5 DATA TRIANGULATION
• 2.6 MARKET SHARE ASSESSMENT
• 2.7 STUDY ASSUMPTIONS
• 2.8 GROWTH ASSUMPTIONS
• 2.9 RISK ASSESSMENT
• 2.10 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 REFURBISHED MEDICAL EQUIPMENT MARKET OVERVIEW
• 4.2 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• 4.3 REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY AND END USER, 2023 (USD MILLION)
• 4.4 GEOGRAPHIC SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increased need for affordable and advanced diagnostic imaging equipment
    • 5.2.1.2 Better warranties and service agreements for refurbished equipment
    • 5.2.1.3 Increased focus on environmental sustainability in healthcare sector
    • 5.2.1.4 Rising healthcare costs and need for cost-saving alternatives
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Lesser reliability in high-regulated sectors and lack of standardized refurbishment processes
    • 5.2.2.2 Availability of cost-effective new medical equipment
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increased acceptability of refurbished equipment by large hospitals and healthcare systems
    • 5.2.3.2 Expansion of online marketplaces and global logistics networks
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of uniform refurbishment standards for medical equipment
    • 5.2.4.2 Rapid innovation in medical technology
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 THREAT OF SUBSTITUTES
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 BARGAINING POWER OF BUYERS
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.5.2 KEY BUYING CRITERIA
• 5.6 PATENT ANALYSIS
  • 5.6.1 LIST OF MAJOR PATENTS
• 5.7 KEY CONFERENCES & EVENTS, 2024-2026
• 5.8 TRADE DATA ANALYSIS
  • 5.8.1 IMPORT DATA FOR HS CODE 9018
  • 5.8.2 EXPORT DATA FOR HS CODE 9018
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT, BY REGION, 2021-2023
  • 5.9.2 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT, BY PRODUCT, 2021-2023
  • 5.9.3 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT, BY KEY PLAYER, 2023
• 5.10 UNMET NEEDS & KEY PAIN POINTS
• 5.11 ECOSYSTEM ANALYSIS
• 5.12 SUPPLY CHAIN ANALYSIS
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 Portable and point-of-care medical devices
    • 5.14.1.2 Diagnostic imaging systems
    • 5.14.1.3 Laboratory, surgical, and therapeutic equipment
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 AI-powered predictive analytics
    • 5.14.2.2 Digital connectivity and telemedicine technologies
    • 5.14.2.3 Remote monitoring technologies
  • 5.14.3 ADJACENT TECHNOLOGIES
    • 5.14.3.1 Robotics and automation technologies
• 5.15 REGULATORY LANDSCAPE
  • 5.15.1 REGULATORY FRAMEWORK
    • 5.15.1.1 North America
      • 5.15.1.1.1 US
      • 5.15.1.1.2 Canada
  • 5.15.2 EUROPE
  • 5.15.3 ASIA PACIFIC
    • 5.15.3.1 Japan
    • 5.15.3.2 China
    • 5.15.3.3 India
  • 5.15.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 REIMBURSEMENT SCENARIO ANALYSIS
• 5.18 IMPACT OF AI/GEN AI ON REFURBISHED MEDICAL EQUIPMENT MARKET

6 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 MEDICAL IMAGING EQUIPMENT
  • 6.2.1 CT SCANNERS
    • 6.2.1.1 Cost-effectiveness and favorable government regulations to propel segment growth
  • 6.2.2 MRI MACHINES
    • 6.2.2.1 Need to reduce healthcare costs and increase focus on technological advancements to aid market growth
  • 6.2.3 X-RAY MACHINES
    • 6.2.3.1 Availability of flexible leasing and financing options to spur adoption
  • 6.2.4 NUCLEAR IMAGING SYSTEMS
    • 6.2.4.1 Public-private investments for purchasing new high-end nuclear imaging systems to limit market growth
  • 6.2.5 ULTRASOUND SYSTEMS
    • 6.2.5.1 Economic downturn and decreased reimbursement for new equipment in developed countries to drive market
  • 6.2.6 PET/SPECT SYSTEMS
    • 6.2.6.1 Reduced electronic wastage to support sustainability initiatives in healthcare
  • 6.2.7 MAMMOGRAPHY SYSTEMS
    • 6.2.7.1 Rising number of breast cancer cases and decreasing cost of refurbished mammography systems to augment market growth
• 6.3 OPERATING ROOM & SURGICAL EQUIPMENT
  • 6.3.1 ANESTHESIA MACHINES
    • 6.3.1.1 Long waiting times for new equipment delivery to support segment growth
  • 6.3.2 ELECTROSURGICAL UNITS
    • 6.3.2.1 Hospital budget limitations and focus on minimally invasive surgeries to promote segment growth
  • 6.3.3 OPERATING ROOM TABLES & LIGHTS
    • 6.3.3.1 Low financial capabilities of healthcare organizations in emerging economies to boost adoption
  • 6.3.4 SURGICAL DISPLAYS
    • 6.3.4.1 High fluctuation in raw material and display panel pricing to propel adoption in healthcare settings
  • 6.3.5 OTHER OPERATING ROOM & SURGICAL EQUIPMENT
• 6.4 PATIENT MONITORS
  • 6.4.1 MULTIPARAMETER MONITORS
    • 6.4.1.1 Increased use of home patient monitoring and low prices compared to mid- and high-acuity monitors to drive segment
  • 6.4.2 FETAL MONITORS
    • 6.4.2.1 Increasing prevalence of obstetric complications and preterm births to fuel adoption
  • 6.4.3 ELECTROCARDIOGRAPHY DEVICES
    • 6.4.3.1 Wide applications of ECG devices in cardiovascular diseases to drive market
  • 6.4.4 PULSE OXIMETERS
    • 6.4.4.1 Introduction of low-cost single-use pulse oximeters to limit market growth
  • 6.4.5 CARDIAC MONITORS
    • 6.4.5.1 Need to reduce healthcare costs and high demand for home monitoring to support market growth
  • 6.4.6 NON-INVASIVE BLOOD PRESSURE MONITORS
    • 6.4.6.1 Growing health awareness and increasing incidence of cardiovascular diseases to propel segment growth
  • 6.4.7 OTHER PATIENT MONITORS
• 6.5 CARDIOLOGY EQUIPMENT
  • 6.5.1 DEFIBRILLATORS
    • 6.5.1.1 Increasing prevalence of CVDs in low-income countries to drive adoption of refurbished defibrillators
  • 6.5.2 HEART-LUNG MACHINES
    • 6.5.2.1 Rising number of cardiac surgeries to support segment growth
  • 6.5.3 OTHER CARDIOLOGY EQUIPMENT
• 6.6 UROLOGY EQUIPMENT
  • 6.6.1 DIALYSIS MACHINES
    • 6.6.1.1 Development of low-cost dialysis products to limit market growth
  • 6.6.2 LITHOTRIPSY DEVICES
    • 6.6.2.1 Increasing cases of kidney and ureteric stones to increase demand for refurbished lithotripsy devices
• 6.7 NEUROLOGY EQUIPMENT
  • 6.7.1 EMG MACHINES
    • 6.7.1.1 Use of EMG nerve monitoring for intraoperative applications to fuel segment growth
  • 6.7.2 EEG MACHINES
    • 6.7.2.1 Reimbursement cuts to increase adoption of refurbished EEG machines
• 6.8 INTENSIVE CARE EQUIPMENT
  • 6.8.1 VENTILATORS
    • 6.8.1.1 Improved refurbishment techniques for upgrading used ventilators to drive growth
  • 6.8.2 INFANT INCUBATORS & WARMERS
    • 6.8.2.1 High global birthrate and increasing number of neonates requiring additional medical intervention to fuel segment growth
• 6.9 INTRAVENOUS THERAPY SYSTEMS
  • 6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND FREQUENT PRODUCT RECALLS TO SUPPORT MARKET GROWTH
• 6.10 ENDOSCOPY EQUIPMENT
  • 6.10.1 RISING DEMAND FOR ENDOSCOPY IN DETECTING CHRONIC DISEASES TO SUPPORT MARKET GROWTH
• 6.11 OTHER MEDICAL EQUIPMENT

7 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 CARDIOLOGY DIAGNOSTIC APPLICATIONS
  • 7.2.1 INCREASING INCIDENCE OF CARDIOVASCULAR AND CARDIO-PULMONARY DISORDERS TO DRIVE MARKET
• 7.3 UROLOGY DIAGNOSTIC APPLICATIONS
  • 7.3.1 LOW BUDGET AVAILABILITY FOR PROCURING NEW UROLOGICAL EQUIPMENT TO AID MARKET GROWTH
• 7.4 NEUROLOGY DIAGNOSTIC APPLICATIONS
  • 7.4.1 BUDGET CONSTRAINTS TO INCREASE DEMAND FOR REFURBISHED MEDICAL EQUIPMENT AND STRATEGIC RESOURCE ALLOCATION
• 7.5 ORTHOPEDIC DIAGNOSTIC APPLICATIONS
  • 7.5.1 GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF TARGET DISEASES TO AID MARKET GROWTH
• 7.6 PHYSIOLOGY DIAGNOSTIC APPLICATIONS
  • 7.6.1 RISING AWARENESS OF EARLY DISEASE DIAGNOSIS AND GROWING FOCUS ON HEALTHY LIFESTYLES TO AUGMENT MARKET GROWTH
• 7.7 EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS
  • 7.7.1 INCREASING NUMBER OF NEONATES IN INTENSIVE CARE UNITS TO PROPEL MARKET GROWTH
• 7.8 ONCOLOGY DIAGNOSTIC APPLICATIONS
  • 7.8.1 HIGH INCIDENCE OF MALIGNANCIES AND INCREASED COST OF NEW MEDICAL IMAGING EQUIPMENT TO FUEL MARKET GROWTH
• 7.9 OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS
  • 7.9.1 INCREASING NUMBER OF MATERNITY CENTERS AND DIAGNOSTIC CLINICS TO SUPPORT MARKET GROWTH
• 7.10 OTHER DIAGNOSTIC APPLICATIONS
• 7.11 CARDIOLOGY THERAPEUTIC APPLICATIONS
  • 7.11.1 LOW COST OF REFURBISHED EQUIPMENT AND HIGH-QUALITY CONTROL MEASURES BY OEMS TO DRIVE MARKET
• 7.12 UROLOGY THERAPEUTIC APPLICATIONS
  • 7.12.1 BUDGETARY CONSTRAINTS IN PROCURING NEW EQUIPMENT TO BOOST MARKET GROWTH
• 7.13 NEUROLOGY THERAPEUTIC APPLICATIONS
  • 7.13.1 GROWING DEMAND FOR REFURBISHED ELECTROSURGERY AND SURGICAL EQUIPMENT TO PROPEL MARKET GROWTH
• 7.14 ORTHOPEDIC THERAPEUTIC APPLICATIONS
  • 7.14.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
• 7.15 PHYSIOLOGY THERAPEUTIC APPLICATIONS
  • 7.15.1 DEARTH OF SKILLED SPECIALISTS IN EMERGING ECONOMIES TO LIMIT MARKET GROWTH
• 7.16 EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS
  • 7.16.1 IMPROVED CRITICAL CARE INFRASTRUCTURE AND NEED FOR MORE ESSENTIAL CARE EQUIPMENT TO AUGMENT MARKET GROWTH
• 7.17 ONCOLOGY THERAPEUTIC APPLICATIONS
  • 7.17.1 GROWING NUMBER OF NON-INVASIVE AND INTERVENTIONAL CANCER TREATMENT PROCEDURES TO AID MARKET SEGMENT
• 7.18 OB/GYNECOLOGY THERAPEUTIC APPLICATIONS
  • 7.18.1 GROWING AWARENESS OF MATERNITY CARE IN EMERGING ECONOMIES TO DRIVE MARKET GROWTH
• 7.19 OTHER THERAPEUTIC APPLICATIONS

8 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 REFURBISHED EQUIPMENT TO IMPROVE HEALTHCARE INFRASTRUCTURE WITHOUT HIGH COST OF NEW DEVICES
• 8.3 DIAGNOSTIC IMAGING CENTERS
  • 8.3.1 INCREASED NEED FOR IMAGING FOR EARLY DETECTION AND TREATMENT PLANNING TO SPUR MARKET GROWTH
• 8.4 ACADEMIC & GOVERNMENT ORGANIZATIONS
  • 8.4.1 REFURBISHED EQUIPMENT TO OFFER FINANCIALLY VIABLE ALTERNATIVE AND REDUCE ELECTRONIC WASTAGE
• 8.5 AMBULATORY CARE CENTERS
  • 8.5.1 INCREASING PREFERENCE FOR OUTPATIENT PROCEDURES TO PROPEL MARKET GROWTH
• 8.6 OTHER END USERS

9 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate refurbished medical equipment market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Budgetary constraints in hospitals and high demand for imaging procedures to aid adoption of refurbished medical equipment
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Well-established pharmaceutical and R&D industry to propel market growth
  • 9.3.3 FRANCE
    • 9.3.3.1 Increasing government pressure to reduce healthcare costs to support market growth
  • 9.3.4 UK
    • 9.3.4.1 Rising preference for new equipment due to better safety and compliance to limit market
  • 9.3.5 ITALY
    • 9.3.5.1 Supportive government policies and focus on value-based healthcare system to boost market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Technological advancements and improved healthcare infrastructure to aid market growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Rapidly changing healthcare infrastructure and favorable government incentives to fuel market growth
  • 9.4.3 JAPAN
    • 9.4.3.1 High geriatric population and favorable health insurance system to propel market growth
  • 9.4.4 INDIA
    • 9.4.4.1 Low cost of refurbished equipment and need for alternatives to healthcare service to support market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Preference for new equipment by government healthcare organizations to limit demand for refurbished medical equipment
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increased insurance coverage and free trade agreements with US to support market growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Growing disease burden and rising awareness about advanced diagnostic and treatment procedures to support market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Favorable investment scenario for refurbished medical device manufacturers to drive market
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REFURBISHED MEDICAL EQUIPMENT MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.4.1 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
  • 10.4.2 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
  • 10.4.3 REFURBISHED PATIENT MONITORS MARKET SHARE, BY KEY PLAYER, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
• 10.8 PRODUCT/BRAND COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 GE HEALTHCARE
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 PHILIPS HEALTHCARE
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 SIEMENS HEALTHINEERS AG
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 STRYKER
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 MnM view
      • 11.1.4.3.1 Key strengths
      • 11.1.4.3.2 Strategic choices
      • 11.1.4.3.3 Weaknesses & competitive threats
  • 11.1.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 CANON MEDICAL SYSTEMS CORPORATION
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
  • 11.1.7 DRAGERWERK AG & CO. KGAA
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 NIHON KOHDEN CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 OLYMPUS CORPORATION
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 AVANTE HEALTH SOLUTIONS
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 SOMA TECH INTL.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 EVERX
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 RADIOLOGY ONCOLOGY SYSTEMS
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 MASTER MEDICAL EQUIPMENT
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 FAIR-MEDICAL INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
  • 11.1.16 FUTURE HEALTH CONCEPTS
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
  • 11.1.17 HILDITCH GROUP LTD.
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
  • 11.1.18 BLOCK IMAGING, INC.
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Deals
• 11.2 OTHER PLAYERS
  • 11.2.1 NATIONWIDE IMAGING SERVICES
  • 11.2.2 PACIFIC HEALTHCARE IMAGING
  • 11.2.3 VENTURE MEDICAL REQUIP
  • 11.2.4 DESERT TECH MEDICAL SYSTEMS INC.
  • 11.2.5 HI-TECH INTERNATIONAL
  • 11.2.6 AMBER DIAGNOSTICS
  • 11.2.7 WHITTEMORE ENTERPRISES
  • 11.2.8 TRACO MEDICAL INC.
  • 11.2.9 US MED-EQUIP
  • 11.2.10 US MEDICAL SYSTEMS
  • 11.2.11 MEDLINE INDUSTRIES, INC.
  • 11.2.12 DIRECTMED IMAGING
  • 11.2.13 AGITO MEDICAL

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료